Fuan Pharmaceutical (Group) Co., Ltd. (SHE:300194)

SHE:300194 Financials Overview

Financials in millions CNY. Fiscal year is January - December.

Revenue & Profits

Chart

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022
Revenue Revenue Growth	1,678	1,738	2,391	2,648	2,422	2,453
Revenue Growth	-18.13%	-27.31%	-9.68%	9.33%	-1.28%	3.58%
Gross Profit Gross Profit Growth	582.44	607.61	1,218	1,367	1,355	1,517
Operating Income Operating Income Growth	47.62	56.69	248.55	184.51	100.24	147.59
Net Income Net Income Growth	62.86	77	279.84	231.87	204.61	-296.91
Earnings Per Share EPS Growth	0.05	0.06	0.24	0.19	0.17	-0.25
EPS Growth	-74.91%	-75.00%	26.32%	11.77%	-	-

Revenue by Geography

Chart

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022
Northeast China Northeast China Growth	28.19	67.38	89.41	108.46	152.74
Northern china Northern china Growth	157.75	239.43	318.08	279.12	278.85
East China East China Growth	655.96	849.47	851.69	753.57	749.9
Southern China Southern China Growth	130.63	192.55	214.83	207.11	213.96
Central China Central China Growth	348.56	487.81	459.93	434.04	364.81
Northwestern Region Northwestern Region Growth	52.26	74.26	80.73	195.33	74.34
Southwest Region Southwest Region Growth	227.73	330.52	477.85	274.6	389.09
Export and Others Export and Others Growth	77.04	66.95	78.28	125.3	164.76
Unallocated Unallocated Growth	60.17	83.1	76.94	44.22	64.71
Total Total Growth	1,738	2,391	2,648	2,422	2,453

Cash & Debt

Chart

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022
Cash & Investments Cash & Investments Growth	919.63	1,037	876.32	996.89	703.74	1,002
Total Debt Total Debt Growth	647.36	800.42	705.78	892.86	714.2	906.03
Net Cash (Debt) Net Cash Growth	272.28	236.24	170.54	104.03	-10.45	95.96
Net Cash Growth	109.00%	38.52%	63.93%	-	-	-68.79%
Net Cash Per Share Net Cash Per Share Growth	0.21	0.18	0.15	0.09	-0.01	0.08

Cash Flow & CapEx

Chart

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022
Operating Cash Flow Operating Cash Flow Growth	369.87	312.32	303.59	328.98	339.5	257.13
Capital Expenditures CapEx Growth	-89.26	-108.43	-241.79	-215.68	-383.1	-413.03
Free Cash Flow Free Cash Flow Growth	280.61	203.89	61.8	113.3	-43.6	-155.91
Free Cash Flow Growth	-	229.94%	-45.46%	-	-	-

Margins

Chart

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022
Gross Margin	34.71%	34.96%	50.91%	51.63%	55.97%	61.85%
Operating Margin	2.84%	3.26%	10.39%	6.97%	4.14%	6.02%
Pretax Margin	4.15%	4.79%	13.05%	10.97%	7.82%	-24.13%
Profit Margin	3.75%	4.43%	11.70%	8.76%	8.45%	-12.10%
FCF Margin	16.72%	11.73%	2.58%	4.28%	-1.80%	-6.35%

Dividends

Chart

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jul 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023
Dividend Per Share Dividend Per Share Growth	0.070	0.070	0.050	0.050	0.050
Dividend Per Share Growth	40.00%	40.00%	0%	0%	-
Dividend Yield	1.91%	1.60%	1.16%	1.19%	1.47%

Valuation

Chart

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jul 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022
PE Ratio	74.76	68.45	18.96	22.47	20.93	-
Forward PE	-	95.55	95.55	95.55	95.55	95.55
P/FCF Ratio	15.69	25.85	85.87	45.99	-	-
PS Ratio	2.62	3.03	2.22	1.97	1.77	2.48

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jul 29, 2026

Data Sources Report a data error